array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3438)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(171) "Ocrelizumab subcutaneous: One-year data demonstrate near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS"
["snippet_en"]=>
string(55) "Roche announced the presentation of data from the […]"
["url"]=>
string(215) "https://www.tecnomedicina.it/ocrelizumab-sottocute-i-dati-a-un-anno-dimostrano-una-soppressione-quasi-completa-delle-recidive-cliniche-e-delle-lesioni-cerebrali-in-pazienti-con-forme-progressive-e-recidivanti-di-sm/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4698e5ff-6eba-4a15-bbcf-10a6a14b9ebc"
["source"]=>
string(16) "tecnomedicina.it"
["publication_date"]=>
string(10) "2024-04-01"
["categories"]=>
array(2) {
[0]=>
string(17) "Academic Research"
[1]=>
string(13) "Data Security"
}
}
[1]=>
array(7) {
["title_en"]=>
string(92) "Reducing regulatory data protection isn’t a successful strategy, says Roche Netherlands GM"
["snippet_en"]=>
string(237) "Reducing regulatory data protection and limiting intellectual property rights isn’t a successful strategy, says Roche Netherlands' General Manager, while encouraging the Dutch government to follow Germany with a pharma strategy summit."
["url"]=>
string(144) "https://www.euractiv.com/section/health-consumers/news/reducing-regulatory-data-protection-isnt-a-successful-strategy-says-roche-netherlands-gm/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e61f28e7-d2e3-4f19-b7fa-824117433737"
["source"]=>
string(12) "euractiv.com"
["publication_date"]=>
string(10) "2024-03-18"
["categories"]=>
array(6) {
[0]=>
string(22) "EU Political Evolution"
[1]=>
string(46) "Management of Legal and Regulatory Environment"
[2]=>
string(13) "Data Security"
[3]=>
string(11) "Legislation"
[4]=>
string(21) "Competitive Behaviour"
[5]=>
string(16) "Customer Privacy"
}
}
[2]=>
array(7) {
["title_en"]=>
string(148) "Health News Roundup: WHO warns of growing resistance to GSK's HIV drug; US to accelerate some payments to hospitals after UnitedHealth hack and more"
["snippet_en"]=>
string(180) "Read more about Health News Roundup: WHO warns of growing resistance to GSK's HIV drug; US to accelerate some payments to hospitals after UnitedHealth hack and more on Devdiscourse"
["url"]=>
string(174) "https://www.devdiscourse.com/article/health/2850051-health-news-roundup-who-warns-of-growing-resistance-to-gsks-hiv-drug-us-to-accelerate-some-payments-to-hospitals-after-uni"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/34080e74-1468-49d7-8739-3b280eca56eb"
["source"]=>
string(16) "devdiscourse.com"
["publication_date"]=>
string(10) "2024-03-05"
["categories"]=>
array(3) {
[0]=>
string(11) "US Politics"
[1]=>
string(5) "R & D"
[2]=>
string(13) "Data Security"
}
}
[3]=>
array(7) {
["title_en"]=>
string(61) "Building Information Modeling for the pharmaceutical industry"
["snippet_en"]=>
string(130) "New research center sets standards with building information modeling, the digital visualization and coordination of building data"
["url"]=>
string(107) "https://www.pharma-food.de/organisation/building-information-modeling-fuer-die-pharma-industrie-72-293.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/82ed7606-bc8b-4b42-baf0-2f7c37d4852b"
["source"]=>
string(14) "pharma-food.de"
["publication_date"]=>
string(10) "2024-02-13"
["categories"]=>
array(5) {
[0]=>
string(5) "R & D"
[1]=>
string(13) "Data Security"
[2]=>
string(18) "Expansion & Growth"
[3]=>
string(16) "Customer Privacy"
[4]=>
string(17) "Academic Research"
}
}
[4]=>
array(7) {
["title_en"]=>
string(145) "Businessmen from Maldonado and Rocha agreed on a “single security protocol” that enables them to “return people to their place of origin”"
["snippet_en"]=>
string(204) "The “guidelines for action in citizen security” combine the old Law of Vagrancy with the Law of Misdemeanors; The text was written with “contributions” from various public and union organizations."
["url"]=>
string(176) "https://ladiaria.com.uy/maldonado/articulo/2024/1/empresarios-de-maldonado-y-rocha-acordaron-protocolo-unico-de-seguridad-que-habilita-a-devolver-personas-a-su-lugar-de-origen/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6de6ac12-0f92-4225-9d34-ae628beeb5c2"
["source"]=>
string(15) "ladiaria.com.uy"
["publication_date"]=>
string(10) "2024-01-18"
["categories"]=>
array(4) {
[0]=>
string(5) "Legal"
[1]=>
string(10) "Cybercrime"
[2]=>
string(11) "Regulations"
[3]=>
string(13) "Data Security"
}
}
[5]=>
array(7) {
["title_en"]=>
string(47) "data science leaders who are shaping the future"
["snippet_en"]=>
string(251) "Join our WhatsApp and Telegram Community to Get Regular Top Tech Updates Disclaimer: Any financial and crypto market information given on Analytics Insight are sponsored articles, written for informational purpose only and is not an investment advice."
["url"]=>
string(81) "https://www.analyticsinsight.net/data-science-leaders-who-are-shaping-the-future/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ecca31f9-21fc-400e-9adb-ef06e45c0bf0"
["source"]=>
string(20) "analyticsinsight.net"
["publication_date"]=>
string(10) "2024-01-08"
["categories"]=>
array(2) {
[0]=>
string(14) "Cryptocurrency"
[1]=>
string(13) "Data Security"
}
}
[6]=>
array(7) {
["title_en"]=>
string(28) "Aug – Data Science Leaders"
["snippet_en"]=>
string(67) "Artificial Intelligence, Big Data Analytics and Cryptocurrency News"
["url"]=>
string(58) "https://www.analyticsinsight.net/aug-data-science-leaders/"
["image_url"]=>
NULL
["source"]=>
string(20) "analyticsinsight.net"
["publication_date"]=>
string(10) "2024-01-03"
["categories"]=>
array(4) {
[0]=>
string(5) "R & D"
[1]=>
string(10) "Cybercrime"
[2]=>
string(16) "Customer Privacy"
[3]=>
string(13) "Data Security"
}
}
[7]=>
array(7) {
["title_en"]=>
string(89) "From hemophilia to lymphomas, Roche presents new data at Ash 2023 - QuotidianodiFoggia.it"
["snippet_en"]=>
string(137) "(Adnkronos) - Important new data on treatments in hematology, such as those for haemophilia A, diffuse large B-cell lymphoma and lymphoma"
["url"]=>
string(90) "https://quotidianodifoggia.it/da-emofilia-a-linfomi-roche-presenta-nuovi-dati-allash-2023/"
["image_url"]=>
NULL
["source"]=>
string(21) "quotidianodifoggia.it"
["publication_date"]=>
string(10) "2023-12-12"
["categories"]=>
array(4) {
[0]=>
string(5) "R & D"
[1]=>
string(16) "Customer Privacy"
[2]=>
string(13) "Data Security"
[3]=>
string(14) "Product Launch"
}
}
[8]=>
array(7) {
["title_en"]=>
string(123) "New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A"
["snippet_en"]=>
string(156) "Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favourable efficacy and safety profile of subcutaneous Hemlibra..."
["url"]=>
string(193) "https://www.globenewswire.com/news-release/2023/12/09/2793433/0/en/New-data-reinforce-the-benefit-of-early-preventative-treatment-with-Roche-s-Hemlibra-for-babies-with-severe-haemophilia-A.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d9aaf87d-f13a-4eac-9b83-802e814b0d9c"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2023-12-09"
["categories"]=>
array(2) {
[0]=>
string(10) "Tax Havens"
[1]=>
string(13) "Data Security"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(217)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(204)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[3]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(156)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(148)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(137)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(136)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(111)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(105)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(102)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(97)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(92)
}
[13]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(89)
}
[14]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(86)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(65)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(64)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(63)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(42)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(40)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(40)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(38)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(33)
}
[25]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(33)
}
[26]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3438 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Reducing regulatory data protection and limiting intellectual property rights isn’t a successful strategy, says Roche Netherlands' General Manager, while encouraging the Dutch government to follow Germany with a pharma strategy summit.
Read more about Health News Roundup: WHO warns of growing resistance to GSK's HIV drug; US to accelerate some payments to hospitals after UnitedHealth hack and more on Devdiscourse
The “guidelines for action in citizen security” combine the old Law of Vagrancy with the Law of Misdemeanors; The text was written with “contributions” from various public and union organizations.
Join our WhatsApp and Telegram Community to Get Regular Top Tech Updates Disclaimer: Any financial and crypto market information given on Analytics Insight are sponsored articles, written for informational purpose only and is not an investment advice.
Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favourable efficacy and safety profile of subcutaneous Hemlibra...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
